Pages that link to "Q40384269"
Jump to navigation
Jump to search
The following pages link to Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease (Q40384269):
Displaying 50 items.
- beta-Amyloid degradation and Alzheimer's disease (Q21284467) (← links)
- SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production (Q24307854) (← links)
- Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins (Q24329069) (← links)
- Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease (Q24682442) (← links)
- Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH (Q24803627) (← links)
- New insights into coupling and uncoupling of cerebral blood flow and metabolism in the brain (Q26745457) (← links)
- Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease (Q26853610) (← links)
- Neuropathological alterations in Alzheimer disease (Q27003314) (← links)
- Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition (Q28143799) (← links)
- Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer's Disease Brain (Q28249933) (← links)
- Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy (Q28550062) (← links)
- Identification of a Novel Parallel β-Strand Conformation within Molecular Monolayer of Amyloid Peptide (Q28821551) (← links)
- Comparison of the structures of beta amyloid peptide (25-35) and substance P in trifluoroethanol/water solution (Q30584433) (← links)
- Sequencing of peptides phosphorylated on serines and threonines by post-source decay in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Q30807438) (← links)
- Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6). (Q31052453) (← links)
- Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. (Q33444709) (← links)
- Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches (Q33546151) (← links)
- Immunological memory to hyperphosphorylated tau in asymptomatic individuals (Q33559360) (← links)
- Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB. (Q33573458) (← links)
- Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide (Q33628181) (← links)
- Microglia and the immune pathology of Alzheimer disease (Q33655115) (← links)
- The biochemistry of Alzheimer's disease (Q33688799) (← links)
- Cholinergic neuromodulation and Alzheimer's disease: from single cells to network simulations. (Q33768496) (← links)
- A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. (Q33838456) (← links)
- NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation (Q33888339) (← links)
- Properties of NACP/alpha-synuclein and its role in Alzheimer's disease (Q33971315) (← links)
- A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA mice (Q34013221) (← links)
- Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths (Q34018579) (← links)
- Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model. (Q34046424) (← links)
- The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review (Q34074186) (← links)
- Amyloid structure: conformational diversity and consequences (Q34175001) (← links)
- Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide (Q34189782) (← links)
- Neuropathology of Alzheimer's disease and other dementias (Q34262766) (← links)
- Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models (Q34305878) (← links)
- Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease (Q34395995) (← links)
- Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization (Q34509815) (← links)
- Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain (Q34531006) (← links)
- Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20 (Q34534448) (← links)
- Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD. (Q34637377) (← links)
- Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice (Q34651703) (← links)
- hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA (Q34670591) (← links)
- Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease (Q34729047) (← links)
- Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation (Q34792306) (← links)
- Amyloid beta inhibits olfactory bulb activity and the ability to smell (Q35005939) (← links)
- The effect of a secreted form of beta-amyloid-precursor protein on intracellular Ca2+ increase in rat cultured hippocampal neurones (Q35027419) (← links)
- Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody (Q35151492) (← links)
- Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold (Q35290019) (← links)
- Protein phosphorylation and APP metabolism (Q35564758) (← links)
- Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography (Q35692953) (← links)
- Do statins slow down Alzheimer's disease? A review (Q35778128) (← links)